Grants>Pathogenesis

Maurice Hilleman/Merck Award

ASM’s premier award for major contributions to pathogenesis, vaccine discovery, vaccine development, and/or control of vaccine-preventable diseases. The award is presented in memory of Maurice R. Hilleman, whose work in the development of vaccines has saved the lives of many throughout the world.

Eligibility:
The nominee must have made outstanding achievements in pathogenesis, vaccine discovery, vaccine development, and/or control of vaccine-preventable diseases.

Award:

A cash prize of $20,000, a commemorative piece, and travel to the ASM General Meeting where the laureate will deliver the Maurice Hilleman/Merck Award lecture.

Deadline:  July 1.

Nominations:
Nominations will be considered without updating for three years. Self-nominations and more than one nomination per nominee will not be accepted. Only one nominating form and two supporting forms are accepted per nomination. The two supporters must be persons other than the nominator who are familiar with the nominee's qualifications and accomplishments. Only one of the three individuals involved in the nomination may be employed at the nominee's institution. The nominator and supporters must not share employers.

Nominations must consist of the following:

Curriculum vitae, including a list of publications, emailed to awards@asmusa.org
Nominating form
Supporting form

ASM awards are granted at the discretion of the award selection committees and may not be awarded every year.

Sponsor: Merck & Co., Inc.

American Society for Microbiology
1752 N Street, N.W.
Washington, D.C. 20036-2904
(202) 737-3600

Call for Nominations: Endocrine Society Clinical Investigator Award Lecture

Deadline: April 1, 2012 (Midnight, Eastern Time)

Established in 1988, the Clinical Investigator Award is presented to an internationally recognized clinical investigator for major contributions to clinical research related to pathogensis, pathophysiology and therapy of endocrine diseases. The recipient presents a plenary lecture at the Endocrine Society’s Annual Meeting and receives an honorarium of $3,000 plus travel expenses to attend the Annual Meeting to accept the award.

Awards will be presented at ENDO 2013 The Endocrine Society's 95th Annual Meeting & Expo June 15-18, 2013 in San Francisco, California.

National Rosacea Society Research Grant Program

The Society awards grants of $10,000 to $25,000 or higher in special cases for research on rosacea. Because the etiology of rosacea is unknown, high priority is given to research in such areas as the pathogenesis, progression, mechanism of action, cell biology and potential genetic factors of this conspicuous and often life-disruptive condition. Studies may also be funded in such areas as epidemiology, predisposition, quality of life and associations with environmental and lifestyle factors. Product development studies (e.g., drug or device testing), which are more appropriately funded by commercial sources, will not be considered.

The National Rosacea Society is currently accepting proposals for research grants to be awarded in 2012. Applications should be submitted by April 16, 2012.

For more information, call the Society at 847/382-8971.

Shwachman Diamond Syndrome Foundation Research Grants

Shwachman-Diamond Syndrome (SDS) is a multi-system autosomal-recessive disorder characterized by exocrine pancreatic dysfunction, and varying degrees of marrow dysfunction with cytopenias. Many associated clinical problems have also been described, including skeletal anomalies, metaphyseal dysostosis, rib abnormalities, cleft palate, dental abnormalities and others. Shwachman-Diamond Syndrome Foundation (SDSF) is a nonprofit support organization actively helping the victims of this disease. SDSF is accepting grant requests for research relevant to this disease. Any high quality, innovative research proposal deemed relevant to SDS will be considered.

The following are areas of particular interest:

Investigate or evaluate potential novel therapies or potential novel therapeutic strategies- preferred applications
Evaluate predictors of bone marrow abnormalities to determine their correlation with the disease
Determine the causes of bone marrow failure and leukemia
Further delineate the pathogenesis of pancreatic disease

Investigations related to adult patient presentation, management, and care including transition from pediatric-centered to adult care

Eligibility

Persons applying for these grants must be in a faculty position with authority to hold an independent research grant (not a training position).

Letter of Intent
The potential applicant should write a one-page letter of intent to the SDSF, indicating the applicant’s position and affiliation, describing their planned project, and explaining its relevance to Shwachman-Diamond Syndrome. These letters are reviewed by SDSF’s Medical and Scientific Advisory Board (MSAB) grant review process.

Purpose
This letter will be used to identify applicants who will be asked to provide a full application.

Dates
The letter is due no later than March 12th. All those who have submitted a letter of intent will receive a reply by April 5th. All Grant Applications must be submitted by May 15th. The final grant decision will be announced by July 31st with a November 1st start date.

Terms of Support
Support may be provided for up to two (2) years in an amount not to exceed $65,000 per year, including expenses. The second year funding will not be released until a Progress Report has been reviewed and approved by the MSAB. The date for the Progress Report is October 1st. Applicants may submit only one grant application at a time, and may hold only one grant at a time.

If you would like us to send you a grant application, have any questions regarding the grant process or have an interest in the disease, please contact SDSF. Please call toll free 1-888-825-SDSF (7373) or via email at info@shwachman-diamond.org.

Shwachman-Diamond Syndrome Foundation
127 Western Avenue
Sherborn, MA 01770